Liquid crystal composition, liquid crystal display device, and liquid crystal display
US-2015376503-A1 · Dec 31, 2015 · US
US2020332195A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020332195-A1 |
| Application number | US-202016832251-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 27, 2020 |
| Priority date | Apr 16, 2019 |
| Publication date | Oct 22, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A PSA-type liquid crystal composition includes a host liquid crystal A and a polymerizable component B, where the host liquid crystal A includes one or more liquid crystal compounds, and the polymerizable component B includes at least one compound selected from compounds of general formula I-1, general formula I-2 and general formula I-3. A liquid crystal display device includes the PSA-type liquid crystal composition above. The PSA-type liquid crystal composition has better intersolubility, cannot be crystallized at a low-temperature environment, can form a relatively stable pretilt angle after the polymerization of the polymerizable component, avoids the image sticking, and inhibits the occurrence of a display defect, such as Zara Particle, during the polymerization.
Opening claim text (preview).
What is claimed is: 1 . A PSA-type liquid crystal composition comprising: a host liquid crystal A and a polymerizable component B, wherein the host liquid crystal A comprises one or more liquid crystal compounds, and the polymerizable component B comprises at least one compound selected from a group consisting of the compounds of general formula I-1, general formula I-2 and general formula I-3: in which, ring A, ring B, ring C, ring D, ring E, ring F, ring G, ring H and ring I each independently represents phenylene or naphthylene; X 1-1 , X 1-2 , X 1-3 , X 2-1 , X 2-2 , X 2-3 , X 2-4 , X 3-1 , X 3-2 , X 3-3 , X 3-4 and X 3-5 each independently represents a single bond, or a C 1-12 linear or branched alkylene, wherein one or more —CH 2 — in the C 1-12 linear or branched alkylene can be replaced by —O—, —S—, —NH—, —CO—, —CH═CH— or —C≡C— in a manner that heteroatoms are not directly connected to each other, —H in one or more —CH 2 — in the C 1-12 linear or branched alkylene can be substituted by halogen, and wherein at least one of X 1-1 , X 1-2 and X 1-3 represents a single bond, at least one of X 2-1 , X 2-2 , X 2-3 and X 2-4 represents a single bond, and at least one of X 3-1 , X 3-2 , X 3-3 , X 3-4 and X 3-5 represents a single bond; R A , R B , R C , R D , R E , R F , R G , R H and R I each independently represents halogen, or a C 1-5 halogenated or unhalogenated linear or branched alkyl or alkoxy; P 1-1 , P 1-2 , P 2-1 , P 2-2 , P 3-1 and P 3-2 each independently represents a polymerizable group; a, b, c, d, e, f, g, h and i each independently represents 0, 1, 2 or 3, and when a is 2 or 3, R A can be same or different; when b is 2 or 3, R B can be same or different; when c is 2 or 3, R C can be same or different; when d is 2 or 3, R D can be same or different; when e is 2 or 3, R E can be same or different; when f is 2 or 3, R F can be same or different; when g is 2 or 3, R G can be same or different; when h is 2 or 3, R H can be same or different; when i is 2 or 3, R I can be same or different; a+b+n 1 ≥1, and n 1 ≥1, wherein n 1 represents the number of groups that are not single bond in X 1-1 , X 1-2 and X 1-3 ; c+d+e+n 2 ≥2, and n 2 ≥1, wherein n 2 represents the number of groups that are not single bond in X 2-1 , X 2-2 , X 2-3 and X 2-4 ; and f+g+h+i+n 3 ≥3, and n 3 ≥1, wherein n 3 represents the number of groups that are not single bond in X 3-1 , X 3-2 , X 3-3 , X 3-4 and X 3-5 . 2 . The PSA-type liquid crystal composition according to claim 1 , wherein a+b+n 1 ≥2; c+d+e+n 2 ≥3; and f+g+h+i+n 3 ≥4. 3 . The PSA-type liquid crystal composition according to claim 1 , wherein X 1-2 , X 2-2 , X 2-3 , X 3-2 , X 3-3 and X 3-4 each independently represents a single bond, —CH 2 O—, —OCH 2 —, —CH 2 CH 2 —, —(CH 2 ) 3 —, —(CH 2 ) 4 —, —(CH 2 ) 3 O—, —O(CH 2 ) 3 —, —O—, —CF 2 —, —CF 2 O—, —OCF 2 —, —CH(CH 3 )CH 2 —, —C(CH 3 ) 2 CH 2 —, —CH 2 C(CH 3 ) 2 —, —C(CH 3 ) 2 CH(CH 3 )—, —C(CH 3 ) 2 C(CH 3 ) 2 —, —C(CH 3 ) 2 O—, —OC(CH 3 ) 2 —, —CH(CH 2 CH 3 )CH 2 —, —S—, —NH—, —NH—CO—O—, —O—CO—NH—, —SCH 2 —, —CH 2 S—, —CH═CH—, —C≡C—, —CH═CH—CO—O— or —O—CO—CH═CH. 4 . The PSA-type liquid crystal composition according to claim 1 , wherein if X 1-2 represents —CO— or —O—CO—, then a+b≠0; if both X 2-2 and X 2-3 represent —CO—O— or —O—CO—, then c+d+e≠0; if all of X 3-2 , X 3-3 and X 3-4 represent —CO—O— or —O—CO—, then f+g+h+i≠0. 5 . The PSA-type liquid crystal composition according to claim 1 , wherein both X 1-1 and X 1-3 represent single bond, and X 1-2 represents —CH 2 O—, —OCH 2 —, —CO—O—, —O—CO—, —CH 2 CH 2 —, —(CH 2 ) 3 —, —(CH 2 ) 4 —, —(CH 2 ) 3 O—, —O(CH 2 ) 3 —, —O—, —CF 2 —, —CF 2 O—, —OCF 2 —, —CH(CH 3 )CH 2 —, —C(CH 3 ) 2 CH 2 —, —CH 2 C(CH 3 ) 2 —, —C(CH 3 ) 2 CH(CH 3 )—, —C(CH 3 ) 2 C(CH 3 ) 2 —, —C(CH 3 ) 2 O—, —OC(CH 3 ) 2 —, —CH(CH 2 CH 3 )CH 2 —, —S—, —NH—, —NH—CO—O—, —O—CO—NH—, —SCH 2 —, —CH 2 S—, —CH═CH—, —C≡C—, —CH═CH—CO—O— or —O—CO—CH═CH. 6 . The PSA-type liquid crystal composition according to claim 1 , wherein the polymerizable component B only comprises one compound of general formula I-1, wherein both X 1-1 and X 1-3 represent single bond, X 1-2 represents —CH 2 O—, —OCH 2 —, —CO—O—, —O—CO—, —CH 2 CH 2 —, —(CH 2 ) 3 —, —(CH 2 ) 4 —, —(CH 2 ) 3 O—, —O(CH 2 ) 3 —, —O—, —CF 2 —, —CF 2 O—, —OCF 2 —, —CH(CH 3 )CH 2 —, —CH 2 C(CH 3 ) 2 —, —C(CH 3 ) 2 CH 2 —, —C(CH 3 ) 2 CH(CH 3 )—, —C(CH 3 ) 2 C(CH 3 ) 2 —, —C(CH 3 ) 2 O—, —OC(CH 3 ) 2 —, —CH(CH 2 CH 3 )CH 2 —, —S—, —NH—, —NH—CO—O—, —O—CO—NH—, —SCH 2 —, —CH 2 S—, —CH═CH—, —C≡C—, —CH═CH—CO—O— or —O—CO—CH═CH—, and a+b 0. 7 . The PSA-type liquid crystal composition according to claim 1 , wherein if the polymerizable component B comprises one compound of general formula I-1 in which a+b+n=1, it at least further comprises another compound selected from a group consisting of the compounds of general formula I-1, general formula I-2 and general formula I-3. 8 . The PSA-type liquid crystal composition according to claim 1 , wherein at least one of X 2-1 and X 2-4 represents a single bond; and when both X 2-1 and X 2-4 represent single bond, at least one of X 2-2 and X 2-3 is not a single bond, and c+d+e≥1. 9 . The PSA-type liquid crystal composition according to claim 1 , wherein if the polymerizable component B comprises two or three polymerizable compounds, and at least one of said two or three polymerizable compounds is selected from the compounds of general formula I-2, at least one of X 2-1 and X 2-4 represents a single bond, and when both X 2-1 and X 2-4 represent single bond, at least one of X 2-2 and X 2-3 is not a single bond, and c+d+e≥1. 10 . The PSA-type liquid crystal composition according to claim 1 , wherein at least one of X 3-1 and X 3-5 represents a single bond; and when both X 3-1 and X 3-5 are single bond, at least one of X 3-2 , X 3-3 and X 3-4 is not a single bond, and f+g+h+i≥2; when only one of X 3-1 and X 3-5 represents a single bond, at most one of X 3-2 , X 3-3 and X 3-4 is not a single bond, and f+g+h+i≥2. 11 . The PSA-type liquid crystal composition according to claim 1 , wherein if the polymerizable component B comprises two or three polymerizable compounds, and at least one of said two or three polymerizable compounds is selected from the compounds of general formula I-3, at least one of X 3-1 and X 3-5 represents a single bond; when both X 3-1 and X 3-5 are single bond, at least one of X 3-2 , X 3-3 and X 3-4 is not a single bond, and f+g+h+i≥2; when only one of X 3-1 and X 3-5 represents a single bond, at most one of X 3-2 , X 3-3 and X 3-4 is not a single bond, and f+g+h+i≥2. 12 . The PSA-type liquid crystal composition according to claim 1 , wherein the host liquid crystal A comprises one or more compounds of general formula M: in which, R M1 and R M2 each independently represents a C 1-12 linear or branched alkyl, one or more nonadjacent —CH 2 — in the C 1-12 linear or branched alkyl can each be independently replaced by —CH═CH—, —C≡C—, —O—, —CO—, —CO—O— or —O—CO—; ring M 1 , ring M 2 and ring M 3 each independently represents wherein one or more —CH 2 — in
Additives having no specific mesophase {characterised by their chemical composition} · CPC title
Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 · CPC title
based on polymer dispersed liquid crystals, e.g. microencapsulated liquid crystals · CPC title
Cy-Cy-Ph · CPC title
stabilizing the alignment; Polymer stabilized alignment · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.